Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 45 out of 100. Long-term cohort studies

Topic: Brain imaging, connectivity and assessment

Alzheimer's Disease (AD) is the most common cause of dementia globally. It steadily worsens from mild to severe, impairing one's ability to complete any work without assistance. It begins to outstrip due to the population ages and diagnosis timeline. For classifying cases, existing approaches incorporate medical history, neuropsychological testing, and Magnetic Resonance Imaging (MRI), but efficient procedures remain inconsistent due to lack of sensitivity and precision. The Convolutional Neural Network (CNN) is utilized to create a framework that can be used to detect specific Alzheimer's disease characteristics from MRI images. By considering four stages of dementia and conducting a particular diagnosis, the proposed model generates high-resolution disease probability maps from the local brain structure to a multilayer perceptron and provides accurate, intuitive visualizations of individual Alzheimer's disease risk. To avoid the problem of class imbalance, the samples should be evenly distributed among the classes. The obtained MRI image dataset from Kaggle has a major class imbalance problem. A DEMentia NETwork (DEMNET) is proposed to detect the dementia stages from MRI. The DEMNET achieves an accuracy of 95.23%, Area Under Curve (AUC) of 97% and Cohen's Kappa value of 0.93 from the Kaggle dataset, which is superior to existing methods. We also used the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset to predict AD classes in order to assess the efficacy of the proposed model.

Key findings

Study details

How this study scored 45/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 2 of 2. 26 of the 58 points it could be judged on, which is 45 of 100. Total 45 of 100.26 of the 58 points we could judge = 45 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 26 of the 58 points we could judge it on, which is 45 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (IEEE Access)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2021 — within 6 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 26 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 26 of the 58 points we could judge it on is 45 out of 100.
Total 45 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Murugan, S., Venkatesan, C., Sumithra, M. G., Gao, X., Elakkiya, B., Akila, M., et al. (2021). DEMNET: A Deep Learning Model for Early Diagnosis of Alzheimer Diseases and Dementia From MR Images. IEEE Access. https://doi.org/10.1109/access.2021.3090474

Vancouver

Murugan S, Venkatesan C, Sumithra MG, Gao X, Elakkiya B, Akila M, et al. DEMNET: A Deep Learning Model for Early Diagnosis of Alzheimer Diseases and Dementia From MR Images. IEEE Access. 2021. doi:10.1109/access.2021.3090474.

BibTeX

@article{murugan2021-896004c6,
  author  = {Murugan, Suriya and Venkatesan, Chandran and Sumithra, M. G. and Gao, Xiao‐Zhi and Elakkiya, B. and Akila, Muthuramalingam and Manoharan, S.},
  title   = {{DEMNET: A Deep Learning Model for Early Diagnosis of Alzheimer Diseases and Dementia From MR Images}},
  journal = {IEEE Access},
  year    = {2021},
  doi     = {10.1109/access.2021.3090474},
  url     = {https://doi.org/10.1109/access.2021.3090474}
}

Related studies in Long-term cohort studies

Also tagged “convolutional”

205 studies in the library carry the topic tag “convolutional”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 205 tagged studies.

Similar studies

More on Long-term cohort studies

See all studies in Long-term cohort studies →